OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Chinese medicine in the treatment of non-alcoholic fatty liver disease based on network pharmacology: a review
Shihao Zheng, Chengyuan Xue, Size Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8
Shihao Zheng, Chengyuan Xue, Size Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8
Showing 8 citing articles:
AlphaFold-Based AI Docking Reveals AMPK/SIRT1-TFEB Pathway Modulation by Traditional Chinese Medicine in Metabolic-Associated Fatty Liver Disease
Lulu Zhang, Yi Zheng, Mingyan Shao, et al.
Pharmacological Research (2025), pp. 107617-107617
Open Access | Times Cited: 1
Lulu Zhang, Yi Zheng, Mingyan Shao, et al.
Pharmacological Research (2025), pp. 107617-107617
Open Access | Times Cited: 1
Patent research in academic literature. Landscape and trends with a focus on patent analytics
Cristian Mejía, Yuya Kajikawa
Frontiers in Research Metrics and Analytics (2025) Vol. 9
Open Access
Cristian Mejía, Yuya Kajikawa
Frontiers in Research Metrics and Analytics (2025) Vol. 9
Open Access
The efficacy of traditional Chinese medicine sequential therapy in non-alcoholic fatty liver disease
Zhang Li, Ying Qian, Hongdi Wu, et al.
Pakistan Journal of Medical Sciences (2025) Vol. 41, Iss. 2, pp. 512-518
Open Access
Zhang Li, Ying Qian, Hongdi Wu, et al.
Pakistan Journal of Medical Sciences (2025) Vol. 41, Iss. 2, pp. 512-518
Open Access
Exploring the mechanism of SLXG for treating nonalcoholic fatty liver disease based on network pharmacology and molecular docking
Yang Wang, Jiaxing Wang, Zitong Chen, et al.
Medicine (2025) Vol. 104, Iss. 6, pp. e40255-e40255
Open Access
Yang Wang, Jiaxing Wang, Zitong Chen, et al.
Medicine (2025) Vol. 104, Iss. 6, pp. e40255-e40255
Open Access
Analysis the Mechanism of <i>Herba</i> <i>Artemisiae</i> <i>s</i><i>copariae</i> and <i>Folium </i><i>n</i><i>elumbinis</i> in the Treatment of Non-Alcoholic Fatty Liver Disease Based on Network Pharmacology
鑫凤 娄
Traditional Chinese Medicine (2025) Vol. 14, Iss. 04, pp. 1253-1262
Closed Access
鑫凤 娄
Traditional Chinese Medicine (2025) Vol. 14, Iss. 04, pp. 1253-1262
Closed Access
Deciphering the mechanism of Chaihu Shugan San in the treatment of nonalcoholic steatohepatitis using network pharmacology and molecular docking
Yi Ren, Kaihui Xiao, Yujia Lu, et al.
Journal of Pharmacy and Pharmacology (2024)
Closed Access | Times Cited: 1
Yi Ren, Kaihui Xiao, Yujia Lu, et al.
Journal of Pharmacy and Pharmacology (2024)
Closed Access | Times Cited: 1
Elucidation of the anti-fibrotic diseases mechanism of chelerythrine by integrative approach of network pharmacology and experimental verification
Wei Han, Gui-yun Qian, Qinrong Wang, et al.
Natural Product Research (2024), pp. 1-7
Closed Access
Wei Han, Gui-yun Qian, Qinrong Wang, et al.
Natural Product Research (2024), pp. 1-7
Closed Access
Bioinformatics based exploration of the anti-NAFLD mechanism of Wang’s empirical formula via TLR4/NF-κB/COX2 pathway
Suhong Chen, Chuanjie Zhou, Jia-Hui Huang, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access
Suhong Chen, Chuanjie Zhou, Jia-Hui Huang, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access
